B Complex Tablet
B Complex Tablet, licence 80113430: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Hownature B Complex Tablet, Nutrition Valley B Complex Tablet
- Licence holder
- Hownature Nutraceutical Corp.
- NPN or DIN-HM
- 80113430
- Status
- Active licence
- Licence date
- 13 October 2021
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Folate Source : Acide folique | 500.0 mcg | Not calculated |
| Acide pantothénique Source : D-Pantéthine | 5.0 mg | 10,000 µg |
| Choline Source : Bitartrate de choline | 30.0 mg | Not calculated |
| Thiamine Source : Mononitrate de thiamine | 50.0 mg | 100,000 µg |
| Niacinamide Source : Niacinamide | 50.0 mg | Not calculated |
Non-medicinal ingredients
Macrogol 3350, Glycolate d'amidon sodique, Carbonate de calcium, Talc, Hydroxypropyl méthylcellulose, Maltodextrine, Dioxyde de titane, Polyvinylpyrrolidone, Cellulose, Laque d'aluminium FD&C Rouge n° 3, Poly(alcool vinylique), Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 ans | 1.0 Comprimé | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps in energy metabolism and in tissue formation. Helps in the normal function of the immune system. Helps normal growth and development. Helps to maintain healthy hair, nail, mucous membranes and/or skin. Helps to maintain normal red blood cells. Helps to maintain the body's ability to metabolize nutrients and helps in tissue formation. Supports energy production.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80113430
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.